Mesa Biotech: Ingo Chakravarty

Mesa Biotech has appointed Ingo Chakravarty as the firm's president and CEO, effective April 15. Chakravarty replaces Hong Cai, a cofounder of Mesa, who has transitioned to be the firm's chief technology officer. Chakravarty most recently served as president and CEO of Navican Genomics, and has held senior leadership positions at GenMark Diagnostics, Gen-Probe, Roche, and Ventana Medical Systems.